Making election promises a reality: Heart & Stroke ready to work with new government on pharmacare, vaping and nutrition
OTTAWA, Oct. 22, 2019 /CNW/ - Heart & Stroke welcomes Canada's newly elected government and is looking forward to working with parliamentarians to improve heart and brain health for people across the country.
"We are looking forward to working with the new government and all parliamentarians on critical health issues such as the creation of a national pharmacare program, restricting the marketing of food and beverages to children, a national school nutrition program and protecting youth from vaping," said Yves Savoie, CEO Heart & Stroke.
Up to 80% of premature heart disease and stroke can be prevented by eating a healthy diet, being physically active, and being smoke-free. Heart disease and stroke are leading causes of death in Canada.
About Heart & Stroke
Life. We don't want you to miss it. That's why Heart & Stroke leads the fight against heart disease and stroke. We must generate the next medical breakthroughs, so people in Canada don't miss out on precious moments. Together, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy.
Pieper Veterinary, a Northeastern-based family of primary, specialty, and emergency care veterinary hospitals, is excited to announce they have partnered with Lebanon Veterinary Hospital in Lebanon CT. This partnership continues Pieper's strategy to...
NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of...
Acadia Pharmaceuticals Inc. today announced that two oral presentations featuring DAYBUEtm (trofinetide) findings in Rett syndrome will be presented at the American Academy of Neurology (AAN) 2024 annual meeting, being held this week in Denver, CO....
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today announced the first patient being dosed in DiaMedica's relaunch of its pivotal...
Jazz Pharmaceuticals plc today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET / 9:30...
In response to the 2024 Federal Budget, Community Food Centres Canada (CFCC) expresses concern over the budget's failure to tackle the pervasive issue of food insecurity in Canada. With 1 in 5 people in Canada living with food insecurity, the federal...